期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

部分肺疾病痰液中相关肿瘤标志物的检测与分析

部分肺疾病痰液中相关肿瘤标志物的检测与分析
暂未订购
导出
摘要 目的探讨呼吸系统中部分病种之间痰液中肿瘤标志物的差异。方法收集肺癌病例、结核病例和正常病例各30例。采用电化学发光法测定CEA、CA-125、CYFRA21-1、NSE。结果肺癌组中各项肿瘤标志物含量明显高于肺结核组和对照组;结核组的各项肿瘤标志物高于对照组。结论①CEA、CA-125、CYFRA21-1、NSE的含量明显高于肺结核组,故检测痰液中CYFRA21-1、NSE的含量可以作为肺癌与肺结核的辅助诊断指标;②肺癌组痰液中CEA、CA-125、CYFRA21-1、NSE的含量高于对照组;③肺结核组痰液中CEA、CA-125、CYFRA21-1的含量明显高于对照组。 Objective To investigate the respiratory disease among some of the sputum of different tumor markers.Methods Lung cancer cases,tuberculosis cases,and control of all 30 patients.Electrochemical luminescence determination of CEA,CA-125,CYFRA21-1,NSE.Results Lung cancer group,the tumor markers were significantly higher than that of tuberculosis and control groups;TB group higher than the tumor marker.Conclusion ① lung cancer in sputum CEA,CA-125,CYFRA21-1,NSE were significantly higher than the tuberculosis group,so detection of sputum CYFRA21-1,NSE levels of lung cancer and pulmonary tuberculosis as a diagnostic marker;②lung cancer sputum CEA,CA-125,CYFRA21-1,NSE levels higher;③ tuberculosis in sputum CEA,CA-125,CYFRA21-1 were significantly higher
作者 李静 王兴宁 刘亚东
机构地区 延安市人民医院 延安大学附属医院
出处 《当代医学》 2011年第15期12-13,共2页 Contemporary Medicine
关键词 肺癌 肺结核 肿瘤标志物 Lung Cancer Tuberculosis Tumor marker
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献7

二级参考文献45

  • 1宋鉴清,吴广平,赵敏,王丽,孙明喜,张丽霞.胸腔积液中CYFRA21-1、NSE的检测对肺癌的诊断意义[J].中国肺癌杂志,2005,8(3):226-226. 被引量：15
  • 2Watanabe R,Takiguchi Y, Kuriyama T. Serum Tumor Markers for Primary Lung Carcinoma[J]. Nippon Rinsho, 2000,58 (5) : 1070-1073.
  • 3Ando S,Kimura H,Iwai N,et al. Optimal Combination of Seven Tumour Markers in Prediction of Advanced Stage at First Examination of Patients with Non-small Cell Lung Cancer[J]. Anticaneer Res,2001,21(4B) :3085-3092.
  • 4Gaspar M J,Diez M,Rodriguez A,et al. Clinical Value of CEA and CA125 Regarding Relapse and Metastasis in Resectable Non-small Cell Lung Cancer[J]. Anticancer Res,2003,23(4) : 3427-3432.
  • 5Stieber P, Hasholzner U, Bodenmuller H, et al. CYFRA 21-1. a New Marker in Lung Cancer[J].Cancer, 1993, 72 (3): 707- 713.
  • 6Suzuki H, Ishikawa S, Satoh H, et al. Preoperative CYFRA 21-1 Levels as a Prognostic Factor in C-stage I Non-small Cell Lung Cancer[J].Eur J Cardiothorac Surg, 2007,32(4) : 648- 652.
  • 7Ferrigno D, Buccheri G,Giordano C. Neuron-specific Enolase is an Effective Tumour Marker in Non-small Cell Lung Cancer (NSCLC) [J]. Lung Cancer, 2003,41 (3) : 311-320.
  • 8Vinolas N,Galan MC,Casas F,et al.Tumor markers in response monitoring and prognosis of non small cell lung cancer.Preliminary report[J].Anticancer Res,1998,18(1/B):631～634.
  • 9Foa P,Fornier M,Miceli R,et al.Tumour markers CEA,NSE,SCC,TPA and CYFRA 21.1 in respectable non-small lung cancer[J].Anticancer Res,1999,19(4c):3613～3618.
  • 10Bonner JA, Sloan JA, Rowland KM Jr, et al. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clin Cancer Res,2000,6(2) : 597-601.

共引文献37

当代医学
2011年 第15期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部